89bio ( NASDAQ: ETNB ) on Tuesday said it has commenced an underwritten public offering of $100 million of shares of its common stock and pre-funded warrants. In addition, 89bio is expected to grant the underwriters of the offering an option for a period.
Back to Health Page
